Cargando…
MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma
Interleukin enhancer binding factor 2 (ILF2) has been found to be markedly upregulated in pancreatic carcinoma and is involved in the pathogenesis of pancreatic carcinoma. Thus, ILF2 may be a potential target for therapy. Yet, the regulatory mechanisms of ILF2 in pancreatic carcinoma remain largely...
Autores principales: | Bi, Yiliang, Shen, Wei, Min, Min, Liu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360436/ https://www.ncbi.nlm.nih.gov/pubmed/28259961 http://dx.doi.org/10.3892/ijmm.2017.2894 |
Ejemplares similares
-
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
por: Glover, Anthony R., et al.
Publicado: (2015) -
Regulation of Pancreatic microRNA-7 Expression
por: Kredo-Russo, Sharon, et al.
Publicado: (2012) -
ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease
por: Bremer, Hanna D., et al.
Publicado: (2018) -
microRNA-184 functions as tumor suppressor in renal cell carcinoma
por: SU, ZHENGMING, et al.
Publicado: (2015) -
Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)